TraceLink Inc. announced that Chester Medical Solutions has become the first UK-based CDMO to select TraceLink’s EU FMD Express solution to help its global pharmaceutical brand customers comply with the rapidly approaching deadline for the EU Falsified Medicines Directive (FMD) in February 2019.
NORTH READING, Mass., July 24, 2018 /PRNewswire/ -- TraceLink, Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that Chester Medical Solutions has become the first UK-based CDMO to select TraceLink’s EU FMD Express solution to help its global pharmaceutical brand customers comply with the rapidly approaching deadline for the EU Falsified Medicines Directive (FMD) in February 2019.
One of the UK’s leading contract development and manufacturing organizations (CDMO), Chester Medical Solutions has a 50 year history of providing flexible, innovative and cost-effective solutions to pharmaceutical and medical device brand owners. Chester Medical Solution’s GMP facility is fitted out to the highest standards, providing a comprehensive range of services with dedicated suites that contain processes such as blister packing, pot, bottle and sachet filling as well as medical device manufacture, assembly and liquid filling.
After equipping its contract packaging site with an advanced inspection system, Chester Medical Solutions selected TraceLink’s EU FMD Express solution and Automated Validation Manager, to offer fully compliant EU FMD services to its clients, including aggregation and the ability to re-work previously serialized product.
“As one of the first UK packaging companies to implement fully compliant EU FMD services, we made the decision to invest in serialization to ensure that our customers are ahead of the curve in being prepared for February 2019 deadline. We offer a wide range of innovative printing and packaging services and TraceLink was the only solution provider that could accommodate our exacting needs, while providing our customers with continuous compliance by enabling us to exchange critical product data with them,” said Ian Robinson, Director of Business Development of Chester Medical Solutions.
Designed specifically for smaller companies, TraceLink’s EU FMD Express provides a simple approach for companies to meet EU FMD compliance while controlling costs and minimizing business impact. As part of the EU FMD Express offering, TraceLink executes the entire deployment and utilizes purpose-built templates and compliance modules, allowing for faster implementation and predictable costs.
To learn more about EU FMD Express and see how TraceLink provides smaller pharmaceutical companies with unmatched flexibility and predictability while eliminating the uncertainty of high costs from CMO integrations and time-intensive implementations, please visit: https://www.tracelink.com/solutions/eu/eu-fmd-for-small-pharma.
About TraceLink
TraceLink is the World’s Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte’s Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
View original content:http://www.prnewswire.com/news-releases/chester-medical-solutions-selects-tracelink-for-serialization-to-achieve-eu-fmd-compliance-for-its-pharma-customers-300685579.html
SOURCE TraceLink Inc.
